Skip to ContentSkip to Navigation
About us Practical matters How to find us dr. J.D. Lefrandt

Publications

Change in telomere length and cardiovascular risk factors in testicular cancer survivors

Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events

Cardiovascular Disease in Testicular Cancer Survivors: Identification of Risk Factors and Impact on Quality of Life

Fluctuations in thyroid hormone levels during initial treatment for differentiated thyroid carcinoma are associated with changes in hemostasis: a prospective cohort study

Physical exercise in patients with testicular cancer treated with bleomycin, etoposide and cisplatin chemotherapy - pulmonary and vascular endothelial function: an exploratory analysis

Adjuvant aromatase inhibitor therapy and early markers for cardiovascular disease in breast cancer survivors

Optimal Timing of a Physical Exercise Intervention to Improve Cardiorespiratory Fitness: During or After Chemotherapy

Shared-care survivorship program for testicular cancer patients: safe and feasible

Cardiovascular effects of overt and subclinical hyperthyroidism: focus on differentiated thyroid cancer

Cognitive Impairment in Long-Term Survivors of Testicular Cancer More Than 20 Years after Treatment

Read more